ondansetron has been researched along with Acute Brain Injuries in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravenous migraine therapy reduces PTH pain scores for children presenting within 14 days after mTBI." | 1.42 | Intravenous migraine therapy in children with posttraumatic headache in the ED. ( Byczkowski, T; Chan, S; Kurowski, B; Timm, N, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roczniak, W | 1 |
| Chan, S | 1 |
| Kurowski, B | 1 |
| Byczkowski, T | 1 |
| Timm, N | 1 |
2 other studies available for ondansetron and Acute Brain Injuries
| Article | Year |
|---|---|
Assessment of dopamine (DA) synthesis rate in selected parts of the rat brain with central noradrenergic lesion after administration of 5-HT3 receptor ligands.
Topics: Adrenergic Neurons; Animals; Benzylamines; Brain Injuries; Brain Stem; Carboxy-Lyases; Dopamine; Fro | 2013 |
Intravenous migraine therapy in children with posttraumatic headache in the ED.
Topics: Adolescent; Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Brain Injuries; | 2015 |